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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
18.05.2020 Psychiatric and 
neuropsychiatric 
presentations 
associated with 
severe 
coronavirus 
infections: a 
systematic review 
and meta-
analysis with 
comparison to the 
COVID-19 
pandemic  
The Lancet 
Psychiatry | 
Article 
 This SR/meta-analysis looks at the 
psychiatric and neuropsychiatric 
consequences of coronavirus 
infections in 3,550 patients 
hospitalised with SARS, MERS and 
COVID-19 
 If infection with SARS-CoV-2 
follows a similar course to that with 
SARS-CoV or MERS-CoV, most 
patients should recover without 
experiencing mental illness 
 SARS-CoV-2 might cause delirium 
in a significant proportion of 
patients in the acute stage 
 Clinicians should be aware of the 
possibility of depression, anxiety, 
fatigue, post-traumatic stress 
disorder, and rarer neuropsychiatric 
syndromes in the longer term 
18.05.2020 A clinical risk 
score to identify 
patients with 
Covid-19 at high 
risk of critical care 
The Lancet 
Infectious 
Diseases | 
SSRN 
Preprint 
 This observational cohort study of 
1,157 patients acutely admitted to 
two London hospitals identified 
predictors of critical care admission 
and death in people admitted to 
hospital with COVID-19 and 
positive SARS-CoV-2 swab results 
2 
admission or 
death : an 
observational 
cohort study 
 These predictors were incorporated 
into a risk score that will inform 
clinical care and stratify patients for 
clinical trials 
15.05.2020 Risks and impact 
of angiotensin-
converting 
enzyme inhibitors 
or angiotensin-
receptor blockers 
on SARS-CoV-2 
infection in adults 
Annals of 
Internal 
Medicine | A 
Living 
Systematic 
Review 
 High-certainty evidence suggest 
that ACEI or ARB use is not 
associated with more severe 
COVID-19 disease 
 Moderate-certainty evidence 
suggests no association between 
use of these medications and 
positive SARS-CoV-2 test results 
among symptomatic patients 
 It remains uncertain whether these 
medications increase the risk for 
mild or asymptomatic disease or 
are beneficial in COVID-19 
treatment 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
19.05.2020 Using a delay-
adjusted case 
fatality ratio to 
estimate under-
reporting 
CMMID | Real 
time report 
last update 
19.05.2020 
(not yet peer 
reviewed) 
 Estimates of the percentage of 
symptomatic COVID-19 cases in 
different countries using case fatality 
ratio estimates based on data from 
the ECDC, correcting for delays 
between confirmation-and-death 
18.05.2020 Susceptible 
supply limits 
the role of 
climate in the 
early SARS-
CoV-2 
pandemic 
Science | 
Report 
 Using a climate-dependent epidemic 
model to simulate the SARS-CoV-2 
pandemic outputs suggests that while 
variations in weather may be 
important for endemic infections, 
during the pandemic stage of an 
emerging pathogen the climate drives 
only modest changes to pandemic 
size 
 Results imply that both tropical and 
temperate locations should prepare 
for severe outbreaks of the diseases 
and that summertime temperatures 
will not effectively limit the spread of 
infection  
 Climate maybe important in the 
longer term where endemic cycles of 
the disease will likely be tied to 
3 
climate factors and seasonal peaks 
may vary with latitude  
15.05.2020 Inferring 
change points 
in the spread of 
COVID-19 
reveals the 
effectiveness of 
interventions 
Science | 
Article 
 This modelling approach allows 
detection and quantification of the 
effect of governmental interventions 
and forecasting future case number 
scenarios 
 Analysis highlights the importance of 
the precise timing and magnitude of 
interventions for future case numbers 
and the importance of including the 
reporting delay between the date of 
infection and the date of the 
confirmed cases in the model 
 The code is freely available and can 
be readily adapted to any country or 
region 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
19.05.2020 Screening for 
COVID-19: 
Patient 
factors 
predicting 
positive PCR 
test 
Infection 
Control & 
Hospital 
Epidemiology | 
Article 
 The selection of patients for SARS-
CoV-2 screening remains challenging 
as many factors influence the decisions 
on which patients to screen, including 
test resources, test accuracy and local 
disease prevalence 
 Strategies are needed to best utilise 
testing resources 
 This retrospective study of patients 
screened between 12 March 2020 to 26 
March 2020 in the US found that 
exposure to confirmed SARS-CoV-2 
and recent travel were both significantly 
more predictive of a positive test than 
the presence of any symptoms 
suggesting a role for testing patients 
with these risk factors regardless of 
symptom presence 
  
4 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
17.05.2020 What are the 
effects of 
convalescent 
plasma for 
people with 
COVID-19? 
Cochrane 
Clinical 
Answers 
 Reviewers identified two case studies 
and six small case series evaluating 
convalescent plasma for people with 
COVID-19 that included 32 
participants 
 All evidence was rated as very low 
certainty with a lack of higher-quality 
studies  
 It remains unclear whether these 
results are related to convalescent 
plasma therapy, to the underlying 
natural history of COVID-19, or to 
other concomitant treatments 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
19.05.2020 Update on the ongoing Novel 
Coronavirus (COVID-19) Global 
Epidemic, Brief #18 
Africa CDC  
18.05.2020 Planning for a COVID-19 vaccination 
program 
JAMA | Viewpoint Sarah 
Schaffer 
DeRoo 
Natalie J. 
Pudalov 
Linda Y. Fu 
18.05.2020 What can psychiatrists learn from 
SARS and MERS outbreaks?  
The Lancet Psychiatry 
| Comment 
Iris E Sommer 
P Roberto 
Bakker 
18.05.2020 Somalia sees “massive” rise in FGM 
during lockdown and Ramadan 
All Africa | News Emma Batha 
5 
15.05.2020 Wrong but useful – what Covid-19 
epidemiologic models can and cannot 
tell us 
NEJM | Perspective Ingra 
Holmdahl 
Caroline 
Buckee 
15.05.2020 Drug researchers pursue new lines of 
attack against COVID-19 
Nature Biotechnology | 
News 
Charlotte 
Harrison 
12.05.2020 Neglected refugees find themselves 
even more neglected during COVID-
19 
African Arguments | 
Blog 
Lucy Hovil 
Vittorio Capici 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
12.05.2020 Guidance on 
community 
physical 
distancing during 
COVID-19 
pandemic 
Africa CDC 
| Guidance 
 Revised guidance accommodating 
new evidence 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
 FIND 
SARS-
CoV-2 
Diagnostic
  US NIH 
registered 
Vaccine 
Centre 
LSHTM 
6 
Platform 
(ICTRP) 
s: 
performanc
e data 
clinical 
trials 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
 COVID-
19 
Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
7 
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Region
al & 
Country 
Academi
c journals 
& 
Publisher
s 
Global Health 
Institutes/Centres/Funders/O
ther 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicatio
n 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
Cambridg
e 
Universit
y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University 
 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academ
y of 
Science
s 
Cochrane  Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
8 
UN Women Africa 
Evidenc
e 
Network 
Elsevier CMMID Repository     
UNOCHA OCHA 
Souther
n and 
Eastern 
Africa 
COVID-
19 
Digest 
JAMA 
Network 
Norwegian Institute of Public 
Health 
    
UNHCR   The 
Lancet 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints
) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
      
World Bank   Science       
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
  SSRN 
(Preprints
)  
      
9 
David 
Nabarro 
Reliefweb   Wiley       
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
10 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
11 
version will 
commence 
early June 
2020 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
12 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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